{"entity":{"type":"insider","cik":"0001405712","url":"/insider/0001405712","json_url":"/insider/0001405712.json","name":"Presidio Partners 2007, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":103,"n_filings":31,"first":"2014-02-12","last":"2018-07-26","span_basis":"filed_date"},"name_variants":[{"name":"Presidio Partners 2007, L.P.","source":"filing","n_filings":3,"first_seen":"2016-04-15","last_seen":"2018-07-26"},{"name":"CMEA Ventures VII LP","source":"filing","n_filings":28,"first_seen":"2014-02-12","last_seen":"2015-02-17"}],"transactions":[{"id":6749567,"accession":"0001144204-18-040247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-18-040247","line_url":"/filing/0001144204-18-040247#line-2","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Menlo Therapeutics Inc.","issuer_ticker":"MNLO","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Watson James F; Presidio Partners 2007 (Parallel), L.P.; Sohail Faysal A.; Collier David J; Presidio Partners 2007 GP, L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":487500.0,"shares_display":"487,500","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":3729375.0,"total_display":"3,729,375.00","shares_owned_after":1907568.0,"shares_owned_after_display":"1,907,568","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2018-07-26","scope":"insider"},{"id":6749563,"accession":"0001144204-18-040247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-040247","line_url":"/filing/0001144204-18-040247#line-1","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Menlo Therapeutics Inc.","issuer_ticker":"MNLO","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Watson James F; Presidio Partners 2007 (Parallel), L.P.; Sohail Faysal A.; Collier David J; Presidio Partners 2007 GP, L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":7.65,"price_display":"7.65","price_state":"stated","total_value":95625.0,"total_display":"95,625.00","shares_owned_after":48910.0,"shares_owned_after_display":"48,910","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2018-07-26","scope":"insider"},{"id":2248030,"accession":"0001209191-16-115074","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074#line-6","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8327.0,"shares_display":"8,327","price_per_share":9.8841,"price_display":"9.88","price_state":"stated","total_value":82304.9007,"total_display":"82,304.90","shares_owned_after":1559995.0,"shares_owned_after_display":"1,559,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-20","scope":"insider"},{"id":2248025,"accession":"0001209191-16-115074","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074#line-5","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":213.0,"shares_display":"213","price_per_share":9.8841,"price_display":"9.88","price_state":"stated","total_value":2105.3133,"total_display":"2,105.31","shares_owned_after":39998.0,"shares_owned_after_display":"39,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-20","scope":"insider"},{"id":2248020,"accession":"0001209191-16-115074","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074#line-4","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7097.0,"shares_display":"7,097","price_per_share":10.029,"price_display":"10.03","price_state":"stated","total_value":71175.813,"total_display":"71,175.81","shares_owned_after":1568322.0,"shares_owned_after_display":"1,568,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-20","scope":"insider"},{"id":2248015,"accession":"0001209191-16-115074","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074#line-3","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182.0,"shares_display":"182","price_per_share":10.029,"price_display":"10.03","price_state":"stated","total_value":1825.278,"total_display":"1,825.28","shares_owned_after":40211.0,"shares_owned_after_display":"40,211","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-20","scope":"insider"},{"id":2248009,"accession":"0001209191-16-115074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074#line-2","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4434.0,"shares_display":"4,434","price_per_share":10.0996,"price_display":"10.10","price_state":"stated","total_value":44781.6264,"total_display":"44,781.63","shares_owned_after":1575419.0,"shares_owned_after_display":"1,575,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-20","scope":"insider"},{"id":2248004,"accession":"0001209191-16-115074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074#line-1","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114.0,"shares_display":"114","price_per_share":10.0996,"price_display":"10.10","price_state":"stated","total_value":1151.3544,"total_display":"1,151.35","shares_owned_after":40393.0,"shares_owned_after_display":"40,393","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-20","scope":"insider"},{"id":3352690,"accession":"0001209191-16-114436","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-10","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10735.0,"shares_display":"10,735","price_per_share":10.1255,"price_display":"10.13","price_state":"stated","total_value":108697.2425,"total_display":"108,697.24","shares_owned_after":1586873.0,"shares_owned_after_display":"1,586,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-15","scope":"insider"},{"id":3352687,"accession":"0001209191-16-114436","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-9","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7020.0,"shares_display":"7,020","price_per_share":10.3176,"price_display":"10.32","price_state":"stated","total_value":72429.552,"total_display":"72,429.55","shares_owned_after":1579853.0,"shares_owned_after_display":"1,579,853","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-15","scope":"insider"},{"id":3352685,"accession":"0001209191-16-114436","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-8","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275.0,"shares_display":"275","price_per_share":10.1255,"price_display":"10.13","price_state":"stated","total_value":2784.5125,"total_display":"2,784.51","shares_owned_after":40687.0,"shares_owned_after_display":"40,687","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-15","scope":"insider"},{"id":3352683,"accession":"0001209191-16-114436","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-7","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180.0,"shares_display":"180","price_per_share":10.3176,"price_display":"10.32","price_state":"stated","total_value":1857.168,"total_display":"1,857.17","shares_owned_after":40507.0,"shares_owned_after_display":"40,507","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-15","scope":"insider"},{"id":3352682,"accession":"0001209191-16-114436","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-6","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13714.0,"shares_display":"13,714","price_per_share":10.2665,"price_display":"10.27","price_state":"stated","total_value":140794.781,"total_display":"140,794.78","shares_owned_after":1610283.0,"shares_owned_after_display":"1,610,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-15","scope":"insider"},{"id":3352679,"accession":"0001209191-16-114436","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-5","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12675.0,"shares_display":"12,675","price_per_share":10.3182,"price_display":"10.32","price_state":"stated","total_value":130783.185,"total_display":"130,783.18","shares_owned_after":1597608.0,"shares_owned_after_display":"1,597,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-15","scope":"insider"},{"id":3352677,"accession":"0001209191-16-114436","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-4","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":352.0,"shares_display":"352","price_per_share":10.2665,"price_display":"10.27","price_state":"stated","total_value":3613.808,"total_display":"3,613.81","shares_owned_after":41287.0,"shares_owned_after_display":"41,287","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-15","scope":"insider"},{"id":3352674,"accession":"0001209191-16-114436","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-3","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325.0,"shares_display":"325","price_per_share":10.3182,"price_display":"10.32","price_state":"stated","total_value":3353.415,"total_display":"3,353.42","shares_owned_after":40962.0,"shares_owned_after_display":"40,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-15","scope":"insider"},{"id":3352670,"accession":"0001209191-16-114436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-2","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12375.0,"shares_display":"12,375","price_per_share":10.1619,"price_display":"10.16","price_state":"stated","total_value":125753.5125,"total_display":"125,753.51","shares_owned_after":1623997.0,"shares_owned_after_display":"1,623,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-13","filed_date":"2016-04-15","scope":"insider"},{"id":3352668,"accession":"0001209191-16-114436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436#line-1","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":317.0,"shares_display":"317","price_per_share":10.1619,"price_display":"10.16","price_state":"stated","total_value":3221.3223,"total_display":"3,221.32","shares_owned_after":41639.0,"shares_owned_after_display":"41,639","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-04-13","filed_date":"2016-04-15","scope":"insider"},{"id":8573412,"accession":"0001209191-15-014665","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-014665","line_url":"/filing/0001209191-15-014665#line-6","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40786.0,"shares_display":"40,786","price_per_share":62.983,"price_display":"62.98","price_state":"stated","total_value":2568824.638,"total_display":"2,568,824.64","shares_owned_after":2965521.0,"shares_owned_after_display":"2,965,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-13","filed_date":"2015-02-17","scope":"insider"},{"id":8573408,"accession":"0001209191-15-014665","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-014665","line_url":"/filing/0001209191-15-014665#line-5","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1047.0,"shares_display":"1,047","price_per_share":62.983,"price_display":"62.98","price_state":"stated","total_value":65943.201,"total_display":"65,943.20","shares_owned_after":76089.0,"shares_owned_after_display":"76,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-13","filed_date":"2015-02-17","scope":"insider"},{"id":8573404,"accession":"0001209191-15-014665","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-014665","line_url":"/filing/0001209191-15-014665#line-4","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66138.0,"shares_display":"66,138","price_per_share":62.9612,"price_display":"62.96","price_state":"stated","total_value":4164127.8456,"total_display":"4,164,127.85","shares_owned_after":3018982.0,"shares_owned_after_display":"3,018,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-12","filed_date":"2015-02-17","scope":"insider"},{"id":8573400,"accession":"0001209191-15-014665","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-014665","line_url":"/filing/0001209191-15-014665#line-3","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12675.0,"shares_display":"12,675","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":811200.0,"total_display":"811,200.00","shares_owned_after":3006307.0,"shares_owned_after_display":"3,006,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-12","filed_date":"2015-02-17","scope":"insider"},{"id":8573397,"accession":"0001209191-15-014665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-014665","line_url":"/filing/0001209191-15-014665#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1696.0,"shares_display":"1,696","price_per_share":62.9612,"price_display":"62.96","price_state":"stated","total_value":106782.1952,"total_display":"106,782.20","shares_owned_after":77461.0,"shares_owned_after_display":"77,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-12","filed_date":"2015-02-17","scope":"insider"},{"id":8573392,"accession":"0001209191-15-014665","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-014665","line_url":"/filing/0001209191-15-014665#line-1","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325.0,"shares_display":"325","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":20800.0,"total_display":"20,800.00","shares_owned_after":77136.0,"shares_owned_after_display":"77,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-12","filed_date":"2015-02-17","scope":"insider"},{"id":9269440,"accession":"0001209191-15-014662","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-014662","line_url":"/filing/0001209191-15-014662#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51773.0,"shares_display":"51,773","price_per_share":61.84,"price_display":"61.84","price_state":"stated","total_value":3201642.32,"total_display":"3,201,642.32","shares_owned_after":3085120.0,"shares_owned_after_display":"3,085,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-17","scope":"insider"},{"id":9269439,"accession":"0001209191-15-014662","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-014662","line_url":"/filing/0001209191-15-014662#line-3","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1327.0,"shares_display":"1,327","price_per_share":61.84,"price_display":"61.84","price_state":"stated","total_value":82061.68,"total_display":"82,061.68","shares_owned_after":79157.0,"shares_owned_after_display":"79,157","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-17","scope":"insider"},{"id":8881587,"accession":"0001209191-15-012032","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-012032","line_url":"/filing/0001209191-15-012032#line-6","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51773.0,"shares_display":"51,773","price_per_share":61.84,"price_display":"61.84","price_state":"stated","total_value":3201642.32,"total_display":"3,201,642.32","shares_owned_after":3112120.0,"shares_owned_after_display":"3,112,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-11","scope":"insider"},{"id":8881585,"accession":"0001209191-15-012032","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-012032","line_url":"/filing/0001209191-15-012032#line-5","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1327.0,"shares_display":"1,327","price_per_share":61.84,"price_display":"61.84","price_state":"stated","total_value":82061.68,"total_display":"82,061.68","shares_owned_after":79157.0,"shares_owned_after_display":"79,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-11","filed_date":"2015-02-11","scope":"insider"},{"id":9269441,"accession":"0001209191-15-014662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-014662","line_url":"/filing/0001209191-15-014662#line-1","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20670.0,"shares_display":"20,670","price_per_share":60.05,"price_display":"60.05","price_state":"stated","total_value":1241233.5,"total_display":"1,241,233.50","shares_owned_after":3136893.0,"shares_owned_after_display":"3,136,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-17","scope":"insider"},{"id":8881583,"accession":"0001209191-15-012032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-012032","line_url":"/filing/0001209191-15-012032#line-4","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20670.0,"shares_display":"20,670","price_per_share":60.05,"price_display":"60.05","price_state":"stated","total_value":1241233.5,"total_display":"1,241,233.50","shares_owned_after":3163893.0,"shares_owned_after_display":"3,163,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-11","scope":"insider"},{"id":8881581,"accession":"0001209191-15-012032","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-012032","line_url":"/filing/0001209191-15-012032#line-3","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":530.0,"shares_display":"530","price_per_share":60.05,"price_display":"60.05","price_state":"stated","total_value":31826.5,"total_display":"31,826.50","shares_owned_after":80484.0,"shares_owned_after_display":"80,484","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-11","scope":"insider"},{"id":8881579,"accession":"0001209191-15-012032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-012032","line_url":"/filing/0001209191-15-012032#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9608.0,"shares_display":"9,608","price_per_share":59.0,"price_display":"59.00","price_state":"stated","total_value":566872.0,"total_display":"566,872.00","shares_owned_after":3157563.0,"shares_owned_after_display":"3,157,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-11","scope":"insider"},{"id":8881577,"accession":"0001209191-15-012032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-012032","line_url":"/filing/0001209191-15-012032#line-1","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":246.0,"shares_display":"246","price_per_share":59.0,"price_display":"59.00","price_state":"stated","total_value":14514.0,"total_display":"14,514.00","shares_owned_after":81014.0,"shares_owned_after_display":"81,014","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-11","scope":"insider"},{"id":8337396,"accession":"0001209191-15-010389","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-010389","line_url":"/filing/0001209191-15-010389#line-6","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29522.0,"shares_display":"29,522","price_per_share":59.48,"price_display":"59.48","price_state":"stated","total_value":1755968.56,"total_display":"1,755,968.56","shares_owned_after":3167171.0,"shares_owned_after_display":"3,167,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-06","filed_date":"2015-02-06","scope":"insider"},{"id":8337392,"accession":"0001209191-15-010389","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-010389","line_url":"/filing/0001209191-15-010389#line-5","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":757.0,"shares_display":"757","price_per_share":59.48,"price_display":"59.48","price_state":"stated","total_value":45026.36,"total_display":"45,026.36","shares_owned_after":81260.0,"shares_owned_after_display":"81,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-06","filed_date":"2015-02-06","scope":"insider"},{"id":8337387,"accession":"0001209191-15-010389","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-010389","line_url":"/filing/0001209191-15-010389#line-4","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12578.0,"shares_display":"12,578","price_per_share":59.51,"price_display":"59.51","price_state":"stated","total_value":748516.78,"total_display":"748,516.78","shares_owned_after":3196693.0,"shares_owned_after_display":"3,196,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-05","filed_date":"2015-02-06","scope":"insider"},{"id":8337382,"accession":"0001209191-15-010389","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-010389","line_url":"/filing/0001209191-15-010389#line-3","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":322.0,"shares_display":"322","price_per_share":59.51,"price_display":"59.51","price_state":"stated","total_value":19162.22,"total_display":"19,162.22","shares_owned_after":82017.0,"shares_owned_after_display":"82,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-05","filed_date":"2015-02-06","scope":"insider"},{"id":8337378,"accession":"0001209191-15-010389","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-010389","line_url":"/filing/0001209191-15-010389#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48750.0,"shares_display":"48,750","price_per_share":59.3,"price_display":"59.30","price_state":"stated","total_value":2890875.0,"total_display":"2,890,875.00","shares_owned_after":3209271.0,"shares_owned_after_display":"3,209,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":8337374,"accession":"0001209191-15-010389","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-010389","line_url":"/filing/0001209191-15-010389#line-1","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":59.3,"price_display":"59.30","price_state":"stated","total_value":74125.0,"total_display":"74,125.00","shares_owned_after":82339.0,"shares_owned_after_display":"82,339","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-06","scope":"insider"},{"id":8801893,"accession":"0001209191-15-008985","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-008985","line_url":"/filing/0001209191-15-008985#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165750.0,"shares_display":"165,750","price_per_share":27.37,"price_display":"27.37","price_state":"stated","total_value":4536577.5,"total_display":"4,536,577.50","shares_owned_after":3158716.0,"shares_owned_after_display":"3,158,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-30","filed_date":"2015-02-03","scope":"insider"},{"id":8801892,"accession":"0001209191-15-008985","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-008985","line_url":"/filing/0001209191-15-008985#line-1","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4250.0,"shares_display":"4,250","price_per_share":27.37,"price_display":"27.37","price_state":"stated","total_value":116322.5,"total_display":"116,322.50","shares_owned_after":80990.0,"shares_owned_after_display":"80,990","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-30","filed_date":"2015-02-03","scope":"insider"},{"id":8802028,"accession":"0001209191-15-014657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-014657","line_url":"/filing/0001209191-15-014657#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3260.0,"shares_display":"3,260","price_per_share":49.129,"price_display":"49.13","price_state":"stated","total_value":160160.54,"total_display":"160,160.54","shares_owned_after":3258021.0,"shares_owned_after_display":"3,258,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-02-17","scope":"insider"},{"id":8802027,"accession":"0001209191-15-014657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-014657","line_url":"/filing/0001209191-15-014657#line-1","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84.0,"shares_display":"84","price_per_share":49.129,"price_display":"49.13","price_state":"stated","total_value":4126.836,"total_display":"4,126.84","shares_owned_after":83589.0,"shares_owned_after_display":"83,589","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-02-17","scope":"insider"},{"id":8079377,"accession":"0001209191-15-003754","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-003754","line_url":"/filing/0001209191-15-003754#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":292500.0,"shares_display":"292,500","price_per_share":24.25,"price_display":"24.25","price_state":"stated","total_value":7093125.0,"total_display":"7,093,125.00","shares_owned_after":3324466.0,"shares_owned_after_display":"3,324,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":8079372,"accession":"0001209191-15-003754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-003754","line_url":"/filing/0001209191-15-003754#line-1","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA VENTURES VII (PARALLEL) LP; CMEA Ventures VII LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":24.25,"price_display":"24.25","price_state":"stated","total_value":181875.0,"total_display":"181,875.00","shares_owned_after":85240.0,"shares_owned_after_display":"85,240","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":7076342,"accession":"0001209191-14-077452","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-077452","line_url":"/filing/0001209191-14-077452#line-4","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190125.0,"shares_display":"190,125","price_per_share":50.14,"price_display":"50.14","price_state":"stated","total_value":9532867.5,"total_display":"9,532,867.50","shares_owned_after":3517374.0,"shares_owned_after_display":"3,517,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-18","filed_date":"2014-12-22","scope":"insider"},{"id":7076339,"accession":"0001209191-14-077452","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-077452","line_url":"/filing/0001209191-14-077452#line-3","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4875.0,"shares_display":"4,875","price_per_share":50.14,"price_display":"50.14","price_state":"stated","total_value":244432.5,"total_display":"244,432.50","shares_owned_after":90240.0,"shares_owned_after_display":"90,240","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-18","filed_date":"2014-12-22","scope":"insider"},{"id":6593689,"accession":"0001209191-14-065571","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-065571","line_url":"/filing/0001209191-14-065571#line-4","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7633.0,"shares_display":"7,633","price_per_share":27.3264,"price_display":"27.33","price_state":"stated","total_value":208582.4112,"total_display":"208,582.41","shares_owned_after":3707499.0,"shares_owned_after_display":"3,707,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-30","filed_date":"2014-10-31","scope":"insider"},{"id":6593687,"accession":"0001209191-14-065571","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-065571","line_url":"/filing/0001209191-14-065571#line-3","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197.0,"shares_display":"197","price_per_share":27.3264,"price_display":"27.33","price_state":"stated","total_value":5383.3008,"total_display":"5,383.30","shares_owned_after":95115.0,"shares_owned_after_display":"95,115","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-30","filed_date":"2014-10-31","scope":"insider"},{"id":6593686,"accession":"0001209191-14-065571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-065571","line_url":"/filing/0001209191-14-065571#line-2","is_derivative":false,"issuer_cik":"0001405712","issuer_name":"Auspex Pharmaceuticals, Inc.","issuer_ticker":"ASPX","issuer_name_source":null,"issuer_url":"/issuer/0001405712","owner_cik":null,"owner_name":"CMEA Ventures VII LP; CMEA VENTURES VII (PARALLEL) LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10891.0,"shares_display":"10,891","price_per_share":27.023,"price_display":"27.02","price_state":"stated","total_value":294307.493,"total_display":"294,307.49","shares_owned_after":3715132.0,"shares_owned_after_display":"3,715,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-29","filed_date":"2014-10-31","scope":"insider"}],"next_cursor":"2014-10-29|6593686","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001566044","name":"Menlo Therapeutics Inc.","url":"/issuer/0001566044","role":"Other","n_filings":1,"first_seen":"2018-07-26","last_seen":"2018-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001467652","name":"Neos Therapeutics, Inc.","url":"/issuer/0001467652","role":"Ten percent owner","n_filings":2,"first_seen":"2016-04-15","last_seen":"2016-04-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001454189","name":"Auspex Pharmaceuticals, Inc.","url":"/issuer/0001454189","role":"Ten percent owner","n_filings":25,"first_seen":"2014-02-12","last_seen":"2015-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001437402","name":"ARDELYX, INC.","url":"/issuer/0001437402","role":"Ten percent owner","n_filings":3,"first_seen":"2014-06-26","last_seen":"2015-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405712","retrieved_at":"2026-08-21T11:37:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}